drugset / Trial / NCT01015066

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

NCT01015066

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to determine the relative effectiveness of buprenorphine/naloxone (Suboxone) pharmacotherapy versus naltrexone pharmacotherapy for treatment retention, relapse prevention and opioid craving reduction among opioid-dependent adolescents and young adults. The investigators hypothesize that naltrexone treatment is as effective as buprenorphine/naloxone for these treatment outcomes.

Timeline

Start
2009-11
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Buprenorphine Other / unclassified 2 mg Other
Comparator Naloxone Small molecule 0.5 mg Other
Subject Naltrexone Small molecule 50 mg Oral

Indications